COM:OCULIS
Oculis
- Stock
Last Close
14.75
22/11 21:00
Market Cap
467.04M
Beta: -
Volume Today
39.61K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
---|---|---|---|---|---|
average inventory | 36K - | ||||
average payables | 807K - | 2.35M 190.64% | 5.73M 144.36% | ||
average receivables | 1.02M - | 994.50K 2.98% | 1.14M 14.73% | ||
book value per share | -1.33 - | -1.86 39.63% | -2.99 60.76% | ||
capex per share | -0.00 - | -0.00 47.37% | -0.11 12,571.43% | ||
capex to depreciation | -0.08 - | -0.12 42.98% | -11.87 9,859.15% | -0.17 98.59% | |
capex to operating cash flow | 0.00 - | 0.00 28.22% | 0.14 6,886.62% | 0.00 99.37% | |
capex to revenue | |||||
cash per share | 0.15 - | 1.41 834.51% | 0.60 57.24% | ||
days of inventory on hand | |||||
days payables outstanding | |||||
days sales outstanding | |||||
debt to assets | 3.35 - | 1.97 41.15% | 3.32 68.69% | 0.01 99.84% | |
debt to equity | -1.26 - | -1.87 49.31% | -1.26 33.00% | 0.01 100.51% | |
dividend yield | |||||
earnings yield | -0.05 - | -0.06 20.48% | -0.13 97.83% | ||
enterprise value | 329.77M - | 357.81M 8.50% | 408.88M 14.27% | -37.72M 109.23% | |
enterprise value over ebitda | -27.26 - | -27.57 1.15% | -12.80 53.59% | ||
ev to operating cash flow | -27.41 - | -25.88 5.59% | -16.31 36.99% | 0.70 104.30% | |
ev to sales | |||||
free cash flow per share | -0.37 - | -0.42 14.98% | -0.87 106.61% | ||
free cash flow yield | -0.04 - | -0.05 11.05% | -0.09 95.95% | ||
graham net net | -1.66 - | -2.20 32.92% | -3.50 58.88% | ||
graham number | 3.69 - | 4.87 31.97% | 8.92 83.12% | ||
income quality | 0.81 - | 0.75 8.24% | 0.65 13.06% | 0.61 6.44% | |
intangibles to total assets | 0.53 - | 0.15 71.77% | 0.33 119.13% | 0.11 67.59% | |
interest coverage | -4.69 - | -2.58 44.94% | -5.03 94.47% | ||
interest debt per share | 1.75 - | 3.65 107.86% | 3.96 8.49% | ||
inventory turnover | |||||
invested capital | -1.26 - | -1.87 49.31% | -1.26 33.00% | 0.01 100.51% | |
market cap | 279.91M - | 289.81M 3.54% | 305.58M 5.44% | ||
net current asset value | -53.87M - | -71.02M 31.82% | -111.39M 56.86% | 80.39M 172.17% | |
net debt to ebitda | -4.12 - | -5.24 27.14% | -3.23 38.30% | ||
net income per share | -0.45 - | -0.57 24.74% | -1.18 108.59% | ||
operating cash flow per share | -0.37 - | -0.42 14.93% | -0.77 81.37% | ||
payables turnover | |||||
receivables turnover | |||||
research and ddevelopement to revenue | |||||
return on tangible assets | -1.94 - | -0.38 80.63% | -1.56 313.92% | ||
revenue per share | |||||
roe | 0.34 - | 0.30 10.67% | 0.39 29.75% | ||
roic | -1.03 - | -0.24 76.32% | -1.26 414.44% | ||
sales general and administrative to revenue | |||||
shareholders equity per share | -1.33 - | -1.86 39.63% | -2.99 60.76% | ||
stock based compensation to revenue | |||||
tangible asset value | -52.38M - | -69.68M 33.03% | -110.20M 58.15% | 81.52M 173.98% | |
tangible book value per share | -1.33 - | -1.86 39.63% | -3.37 80.78% | ||
working capital | 1.82M - | 43.92M 2,310.48% | 11.64M 73.50% | 81.93M 604.02% |
All numbers in USD (except ratios and percentages)